264 related articles for article (PubMed ID: 23598374)
1. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients.
Tuka B; Helyes Z; Markovics A; Bagoly T; Szolcsányi J; Szabó N; Tóth E; Kincses ZT; Vécsei L; Tajti J
Cephalalgia; 2013 Oct; 33(13):1085-95. PubMed ID: 23598374
[TBL] [Abstract][Full Text] [Related]
2. Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache.
Han X; Dong Z; Hou L; Wan D; Chen M; Tang W; Yu S
Clin Chim Acta; 2015 Oct; 450():151-4. PubMed ID: 26296898
[TBL] [Abstract][Full Text] [Related]
3. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine.
Liu J; Wang G; Dan Y; Liu X
J Headache Pain; 2022 Jun; 23(1):68. PubMed ID: 35698032
[TBL] [Abstract][Full Text] [Related]
4. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods.
Hanci F; Kilinc YB; Kilinc E; Turay S; Dilek M; Kabakus N
Cephalalgia; 2021 Feb; 41(2):166-175. PubMed ID: 32903061
[TBL] [Abstract][Full Text] [Related]
6. Release of PACAP-38 in episodic cluster headache patients - an exploratory study.
Tuka B; Szabó N; Tóth E; Kincses ZT; Párdutz Á; Szok D; Körtési T; Bagoly T; Helyes Z; Edvinsson L; Vécsei L; Tajti J
J Headache Pain; 2016 Dec; 17(1):69. PubMed ID: 27475101
[TBL] [Abstract][Full Text] [Related]
7. Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system.
Tuka B; Helyes Z; Markovics A; Bagoly T; Németh J; Márk L; Brubel R; Reglődi D; Párdutz A; Szolcsányi J; Vécsei L; Tajti J
Peptides; 2012 Feb; 33(2):307-16. PubMed ID: 22245521
[TBL] [Abstract][Full Text] [Related]
8. No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.
Cernuda-Morollón E; Riesco N; Martínez-Camblor P; Serrano-Pertierra E; García-Cabo C; Pascual J
Headache; 2016 Oct; 56(9):1448-1454. PubMed ID: 27634731
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period.
Tuka B; Nyári A; Cseh EK; Körtési T; Veréb D; Tömösi F; Kecskeméti G; Janáky T; Tajti J; Vécsei L
J Headache Pain; 2021 Jun; 22(1):60. PubMed ID: 34171996
[TBL] [Abstract][Full Text] [Related]
10. Presence of pituitary adenylate cyclase-activating polypeptide (PACAP) in the plasma and milk of ruminant animals.
Czegledi L; Tamas A; Borzsei R; Bagoly T; Kiss P; Horvath G; Brubel R; Nemeth J; Szalontai B; Szabadfi K; Javor A; Reglodi D; Helyes Z
Gen Comp Endocrinol; 2011 May; 172(1):115-9. PubMed ID: 21185294
[TBL] [Abstract][Full Text] [Related]
11. Blood serum levels of PACAP and migraine onset: A systematic review and meta-analysis of observational studies.
Zhu G; Wang M; Kong F
Headache; 2024 May; 64(5):573-588. PubMed ID: 38659322
[TBL] [Abstract][Full Text] [Related]
12. Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.
Guo S; Vollesen AL; Hansen YB; Frandsen E; Andersen MR; Amin FM; Fahrenkrug J; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):136-147. PubMed ID: 26994298
[TBL] [Abstract][Full Text] [Related]
13. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks.
Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J
Pain; 2000 May; 86(1-2):133-8. PubMed ID: 10779670
[TBL] [Abstract][Full Text] [Related]
14. Correlation of neurochemical and imaging markers in migraine: PACAP38 and DTI measures.
Veréb D; Szabó N; Tuka B; Tajti J; Király A; Faragó P; Kocsis K; Tóth E; Kincses B; Bagoly T; Helyes Z; Vécsei L; Kincses ZT
Neurology; 2018 Sep; 91(12):e1166-e1174. PubMed ID: 30135251
[TBL] [Abstract][Full Text] [Related]
15. Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period.
Gupta R; Ahmed T; Banerjee B; Bhatia M
J Headache Pain; 2009 Jun; 10(3):161-6. PubMed ID: 19277835
[TBL] [Abstract][Full Text] [Related]
16. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine.
Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC
Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383
[TBL] [Abstract][Full Text] [Related]
17. No increase of calcitonin gene-related peptide in jugular blood during migraine.
Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J
Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016
[TBL] [Abstract][Full Text] [Related]
18. High plasma calcitonin gene-related peptide and serum pituitary adenylate cyclase-activating polypeptide levels in patients with neuropathic pain.
Yevgi R; Laloğlu E; Bilge N
Rev Neurol (Paris); 2023 Apr; 179(4):289-296. PubMed ID: 36754669
[TBL] [Abstract][Full Text] [Related]
19. Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide.
Farajdokht F; Babri S; Karimi P; Alipour MR; Bughchechi R; Mohaddes G
Eur J Neurosci; 2017 Mar; 45(6):763-772. PubMed ID: 27886414
[TBL] [Abstract][Full Text] [Related]
20. Role of pituitary adenylate cyclase-activating polypeptide in nociception and migraine.
Tajti J; Tuka B; Botz B; Helyes Z; Vecsei L
CNS Neurol Disord Drug Targets; 2015; 14(4):540-53. PubMed ID: 25921738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
